Упрощенная HTML-версия
135
99.
Breast cancer growth prevention by statins / M. J. Campbell [et al.] // Can-
cer Res. – 2006. – Vol. 66. – P. 8707-8714.
100.
Brookes Z. L. Statins for all: the new premed? / Z. L. Brookes, C. C.
McGown, C. S. Reilly // Br. J. Anaesth. – 2009. – Vol. 103, № 1. – P. 99-
107.
101.
Browning D. R. Statins and risk of cancer: A systematic review and metaa-
nalysis / D. R. L. Browning, R. M. Martin // Int. J. Cancer. – 2006. – Vol.
120, № 4. – P. 833-843.
102.
Brugts J.J.The benefits of statins in people without established cardiovascu-
lar disease but with cardiovascular risk factors: meta-analysis of random-
ized controlled trials. // J.J.Brugts, T. Yetgin, S.E. Hoeks [et al.]. / BMJ. –
2009. – Vol. 338. – Электронныйресурс. Режим доступа:
http://www.bmj.com.
103.
B-type natriuretic peptide as a marker for cardiac dysfunction in anthracy-
cline–treated children / S. Aggarwal [et al.] // Pediatr. Blood Cancer. –
2007. – Vol. 49, № 6. – P. 812-816.
104.
Cardiomyopathy. Early detection and prediction of cardiotoxicity in chem-
otherapy-treated patients / H. Sawaja [et al.] // Am. J. Cardiol. – 2011. –
Vol. 107, № 9. – P. 1375-1380.
105.
Cardioprotection with dexrazoxane for doxorubicin–containing therapy in
advanced breast cancer / S. M. Swain [et al.] // J. Clin. Oncol. – 1997. –
Vol. 15. – P. 1318-1332.
106.
Cardiotoxicity of anticancer drugs: the need for cardio-oncology and car-
dio-oncological prevention / A. Albini [et al.] // J. Natl. Cancer Inst. –
2010. – Vol. 102, № 1. – P. 14-25.
107.
Cardiovascular disease competes with breast cancer as the leading cause of
death for older females diagnosed with breast cancer: a retrospective cohort
study / J. L.Patnaik [et al.] // Breast Cancer Res. – 2011. – Vol. 13, № 3. –
P. 64.